Cannabis Stocks Are Surging Ahead Of House Vote On Marijuana Legalization Next Week

By Sergei Klebnikov, Forbes Staff in Banking & Insurance, Breaking, breaking-news, ETFs & Mutual Funds, Forbes, healthcare, Hedge Funds & Private Equity, Investing, Markets, News, Policy, Vices
March 25, 2022

Sundial and Tilray are up about 50% but the gains may just be temporary.

Read the full post on Forbes - Healthcare

Sergei Klebnikov, Forbes Staff